The 8th annual European Antibody Congress is the industry’s antibody conference covering antibody development, antibody production and monoclonal antibodies.

The European Antibody Congress is the world’s leading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Showcasing major antibody structural improvements, global trends, recent intra-market authorisation and clinical progress, this event sees unrivalled industry participation. Hear, learn, debate and act on the most critical scientific and business opportunities in the antibody sector.

Speak at European Antibody Congress 2012›

Sponsor or exhibit at European Antibody Congress 2012›

Come to the European Antibody Congress 2012 and learn:

How to leverage key issues affecting the shifting global antibodies market
New advances in understanding structure-function relationships in therapeutic antibodies
How to improve efficacy and drugability of monoclonal antibodies
Effective identification of monoclonal antibodies against new targets
How to improve MAb production scale-up, process transfer and comparability
How Antibody Drug Conjugates are on the increase in therapeutic areas
How new scaffolds and technologies are being incorporated in the production of antibodies
Next generation antibodies, including Biosimilars and Biobetters